Amlodipine, Valsartan and Hydrochlorothiazide
These highlights do not include all the information needed to use AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETS. AMLODIPINE, VALSARTAN and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2009
6fba5243-ee00-4825-a04a-321cb6b49c56
HUMAN PRESCRIPTION DRUG LABEL
Jan 6, 2023
Aurobindo Pharma Limited
DUNS: 650082092
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Amlodipine, Valsartan and Hydrochlorothiazide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (13)
Amlodipine, Valsartan and Hydrochlorothiazide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
Amlodipine, Valsartan and Hydrochlorothiazide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
Amlodipine, Valsartan and Hydrochlorothiazide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
Amlodipine, Valsartan and Hydrochlorothiazide
Product Details
FDA regulatory identification and product classification information
